1.
Mohammad Alabdali M, Rafique N, AlDossary DA, Alalloush RS, AlHemli HA, Zeerak M, et al. Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients. J Clin Med Res [Internet]. 2024 Dec. 28 [cited 2025 Jun. 20];16(11):527-35. Available from: https://leojmc.elmerpub.com/index.php/jocmr/article/view/6054